Naloxone reversal of the cardiorespiratory depressant effects of opioids and mixtures of opioids and stimulants in rats
Frontiers in Pharmacology · 22.09.2025 · 16
DOI: 10.3389/fphar.2025.1654791 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 22.09.2025. Verfasst von Jacqueline M Vazquez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Texas Health San Antonio, San Antonio, TX, United States. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDA NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Co-use of opioids (e.g., fentanyl) and stimulants (e.g., methamphetamine; METH) contributed to >30% of the almost 106,000 fatal overdoses in the United States in 2023. Although NarCan ® (naloxone) is effective at reversing opioid-induced cardiorespiratory depression, larger and/or more frequent doses are often required for fentanyl and multi-drug overdoses involving fentanyl. Using collar-based pulse oximetry, this study characterized the effects of intravenous (IV) fentanyl (0.0056–0.56 mg/kg), heroin (0.32–5.6 mg/kg), and METH (0.1–1 mg/kg), as well as mixtures of 0.56 mg/kg fentanyl +1 mg/kg METH and 5.6 mg/kg heroin +1 mg/kg METH on blood oxygen saturation (SpO 2 ), heart rate (HR), and breath rate (BR) in male and female Sprague-Dawley rats. To evaluate the potency and effectiveness of naloxone to reverse cardiorespiratory depression, naloxone (0.01–3.2 mg/kg; IV) or vehicle was administered 5 min after opioids or opioid + stimulant mixtures. Naloxone was fully effective at reversing the effects of fentanyl and heroin alone but was more potent for fentanyl. Naloxone was fully effective and equipotent at reversing the cardiorespiratory effects of heroin and heroin + METH but was less potent and less effective at reversing the cardiorespiratory effects of fentanyl + METH compared to fentanyl alone. When administered after fentanyl, heroin, or heroin + METH, naloxone recovered baseline SpO 2 in all rats, however, SpO 2 was only recovered in 75% of rats treated with fentanyl + METH. These findings suggest that naloxone may be less potent and effective at reversing fentanyl-induced cardiorespiratory depression when METH is co-administered.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, University of Texas Health San Antonio, San Antonio, TX, United States.
- South Texas Veterans Healthcare System, San Antonio, TX, United States.
Förderung
- NIDA NIH HHS
- NINDS NIH HHS
Zitieren
APA
Vazquez, J. M., Seaman, R. W., Caldron, D., & Collins, G. T. (2025). Naloxone reversal of the cardiorespiratory depressant effects of opioids and mixtures of opioids and stimulants in rats. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1654791
Vancouver
Vazquez JM, Seaman RW, Caldron D, Collins GT. Naloxone reversal of the cardiorespiratory depressant effects of opioids and mixtures of opioids and stimulants in rats. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1654791
BibTeX
@article{Vazquez2025,
author = {Vazquez, Jacqueline M and Seaman, Robert W and Caldron, Drew and Collins, Gregory T},
title = {Naloxone reversal of the cardiorespiratory depressant effects of opioids and mixtures of opioids and stimulants in rats},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1654791}
}
EUVIMED